Cargando…
Treatment of Severe Steroid-Refractory Acute-Graft-vs.-Host Disease With Mesenchymal Stem Cells–Single Center Experience
The most effective treatment of steroid refractory acute graft vs. host disease (aGvHD) is not yet established and mesenchymal stem cells (MSC) appear to be a promising therapy for the condition. We report single center case series of three patients, who underwent allogeneic hematopoietic cell trans...
Autores principales: | Česen Mazič, Maja, Girandon, Lenart, Kneževič, Miomir, Avčin, Simona L., Jazbec, Janez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066564/ https://www.ncbi.nlm.nih.gov/pubmed/30087891 http://dx.doi.org/10.3389/fbioe.2018.00093 |
Ejemplares similares
-
Trends in Treatment of Childhood Cancer and Subsequent Primary Neoplasm Risk
por: Cesen Mazic, Maja, et al.
Publicado: (2022) -
Trends in Treatment of Childhood Cancer and Subsequent Primary Neoplasm Risk
por: Cesen Mazic, Maja, et al.
Publicado: (2022) -
Treatment of Rhabdomyosarcoma in Children and Adolescent from Four Low Health Expenditures Average Rates Countries
por: Mazic, Maja Cesen, et al.
Publicado: (2020) -
Excellent results of screening for subsequent breast cancers in long-term survivors of childhood Hodgkin's lymphoma—Results of a population-based study
por: Zadravec Zaletel, Lorna, et al.
Publicado: (2023) -
Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment
por: Primorac, Dragan, et al.
Publicado: (2021)